EDF Health

Selected tag(s): FDA

Why is OMB blocking EPA from using even its limited authority under TSCA?

Richard Denison, Ph.D., is a Senior Scientist.

On May 12 of this year, the Environmental Protection Agency (EPA) sent a proposed rule to the Office of Management and Budget’s (OMB’s) Office of Information and Regulatory Affairs (OIRA) for its review, which is supposed to be completed within 90 days.  The proposed rule is not considered a major rule, is classified as “not economically significant,” imposes no unfunded mandates and is unequivocally allowed under EPA’s statutory authority under the Toxic Substances Control Act (TSCA).

The proposed rule would establish a so-called “chemicals of concern” list and populate it with one chemical and two chemical categories.  All of these chemicals are well-studied, already widely identified to be chemicals of significant concern and subject to numerous regulations by governmental bodies both in the U.S. and abroad.

Yet, as of today – more than seven months after receiving the draft of the proposed rule from EPA – OMB has not allowed EPA to release it for public notice and comment.

In 1976, when passing TSCA, Congress gave EPA the express authority to establish and populate a “chemicals of concern” list.  There’s simply no excuse for OMB’s delay.  Read More »

Posted in Health policy, Regulation / Also tagged , , , , , , , , , | Read 1 Response

Are we ready to get sensible about triclosan use?

Cal Baier-Anderson, Ph.D., is a Health Scientist.

Yesterday the Washington Post reported that the Food and Drug Administration (FDA) is acknowledging that new research raises “valid concerns” about the possible health effects of triclosan, an antimicrobial chemical that can be found in dozens of consumer products as diverse as soaps, personal care products, cutting boards, plastic sandals and even bath towels.

Originally developed as a surgical scrub for use by doctors and nurses, the burgeoning uses of this pesticidal chemical have hugely expanded human and environmental exposures.  With little evidence of any actual public health benefits from such uses, FDA along with the Environmental Protection Agency (EPA) and the Consumer Product Safety Commission (CPSC) should move quickly to limit triclosan use.  Only those uses that have a demonstrable public health benefit, when weighed against potential health and environmental risks, should be allowed. Read More »

Posted in Emerging science, Health science / Also tagged , , , | Read 3 Responses

Superficial science in new nano sunscreen report

Richard Denison, Ph.D., is a Senior Scientist.

I hate to say it, but Friends of the Earth, Consumers Union, and the International Center for Technology Assessment (ICTA) have done a disservice to good science and policy with their new superficial report Manufactured Nanomaterials and Sunscreens: Top Reasons for PrecautionRead More »

Posted in Nanotechnology / Also tagged , | Read 3 Responses

Rebuilding the Consumer Product Safety Commission’s Nano Tool Box

Cal Baier-Anderson, Ph.D., is a Health Scientist.

I have just finished reading yet another depressing/infuriating publication by the Woodrow Wilson Center’s Project on Emerging Nanotechnologies. The new report delineates the many limitations faced by the Consumer Product Safety Commission (CPSC) in addressing nanotechnology health risks.  The law governing the CPSC has significant weaknesses that prevent it from meeting critical needs, such as constraints on the ability to collect data, require reporting of known hazards, order recalls and promulgate mandatory safety standards.

Read More »

Posted in Health policy, Health science, Nanotechnology, TSCA reform / Also tagged , | Comments are closed

Burning Questions: Are Sunscreens Containing Nanomaterials Safe?

Cal Baier-Anderson, Ph.D., is a Health Scientist.

Ah, summer!  It’s a great time to be outdoors, enjoying the warm, sunny weather.  Before you go outside, be sure to grab your sunscreen, that essential product that protects against skin cancer and sun damage.  But which kind of sunscreen is best?  There is a mesmerizing array of sunscreen options, but for our purposes let’s limit the question to one:  Nano or not nano?

Read More »

Posted in Health science, Nanotechnology / Also tagged | Read 4 Responses

The Next Mile Marker on the Road to High Throughput In Vitro Screening?

John Balbus, M.D., M.P.H., is Chief Health Scientist.

A new paper by Shaw et al., published in May in the Proceedings of the National Academy of Sciences, “suggests a generalizable and scalable method for the systematic characterization and comparison of novel nanomaterials” using high throughput in vitro tests.  Does this mean that the National Academy of Sciences’ vision for toxicity testing in the 21st century – proposed for conventional chemicals – is already here for nanomaterials?  Not quite.  Read More »

Posted in Emerging testing methods, Health science, Nanotechnology / Also tagged , , | Comments are closed